Clinical Trial

Comparative Study of Gender Identity Disorder Versus Control

Study acronym: TRANSIDENT
Recruiting
View on ClinicalTrials.gov →
Summary
Gender dysphoria is manifested by an internal tension between biological sex and gender, that is, by a non-congruence, in the subjects who suffer from it, between their sex of birth and their social gender identity.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2021-06-21; most recent amendment 2025-06-03.
Trial Details
NCT Number NCT04935164
Lead Sponsor Centre Hospitalier Henri Laborit
Conditions Gender Dysphoria, Adult
Enrollment 120 participants
Start Date 2021-03-26
Primary Completion 2029-03 (estimated)
Study Completion 2029-12 (estimated)
Updated on ClinicalTrials.gov 2025-06-05